DIHEXA (10mg)

DIHEXA 10 mg (Bisected Tablets)

Advanced Neurogenic Research Compound for Cognitive Pathway Exploration

DIHEXA (PNB-0408) is a highly specialized, peptide-derived small molecule engineered for advanced research into cognitive function, synaptic plasticity, and neuroregenerative signaling pathways. Structurally derived from angiotensin IV, DIHEXA has been modified to significantly enhance lipophilicity, allowing efficient penetration across the blood-brain barrier and targeted interaction within central nervous system pathways.

Unlike traditional nootropic agents that primarily modulate neurotransmitter levels, DIHEXA is being studied for its potential role in neurotrophic activity, specifically its interaction with the hepatocyte growth factor (HGF)/c-Met signaling pathway. This pathway is critically involved in neuronal growth, differentiation, and synapse formation.

Mechanism of Action

DIHEXA is believed to function as a potent HGF mimetic, amplifying signaling through the c-Met receptor. This activation cascade has been associated in research settings with:

• Enhanced synaptogenesis (formation of new synaptic connections)

• Increased neuronal connectivity and signaling efficiency

• Support for long-term potentiation (LTP), a key mechanism underlying learning and memory

• Promotion of neuroplasticity, allowing adaptive restructuring of neural networks

This mechanism positions DIHEXA as a compound of interest in research related to cognitive resilience, memory encoding, and neural repair processes.

Research Applications

DIHEXA is widely utilized in experimental models exploring:

• Cognitive enhancement and memory-related pathways

• Neurodegenerative research (including Alzheimer ’s-related mechanisms)

• Synaptic density and neural network optimization

• Brain-derived signaling and regenerative neuroscience

Its unique ability to influence structural neural changes rather than transient neurotransmitter fluctuations distinguishes it from conventional cognitive research compounds.

Bioavailability & Stability

Due to its high lipophilicity, DIHEXA exhibits strong oral bioavailability in research models and crosses the blood-brain barrier efficiently. Its structural modifications also contribute to improved metabolic stability, enabling sustained interactions within neural environments.

Product Specifications

• Compound Name: DIHEXA (PNB-0408)

• Dosage Form: Bisected Tablets

• Strength: 10 mg per tablet

• Molecular Formula: C₃₄H₅₀N₆O₅

• Molecular Weight: 622.84 g/mol

• CAS Number: 1401708-83-5

Final Note

DIHEXA represents a next-generation compound in neurocognitive research, offering a unique approach through modulation of structural and functional neural pathways rather than surface-level neurotransmitter interactions.

For research purposes only.